Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.

類似資料

• Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.
  著者:: Nasser, S. M., 等
  出版事項: (1994)
• 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
  著者:: Foster, S. J., 等
  出版事項: (1990)
• Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
  著者:: Nasser, S. M., 等
  出版事項: (1994)
• Selective chiral inhibitors of 5-lipoxygenase with anti-inflammatory activity.
  著者:: McMillan, R. M., 等
  出版事項: (1990)
• The in vitro pharmacology of xamoterol (ICI 118,587).
  著者:: Malta, E., 等
  出版事項: (1985)